Companies/US/NUVB

NUVATION BIO INC.

Last · NYSE$4.68-0.04 (-0.85%)close · yahoo · 10h ago
Vol 3.78M ≈ 17.69M
Market cap$1.64B350.1M sh
P/E · TTM-10.6fwd -312 · eps -0.44 · loss
Beta1.62vs S&P 500
Div yield0.00%annual · TTM
52w range
$3.36$9.75
Volume3.8Msession

Issuer

Legal nameNUVATION BIO INC.
HQUnited States (US)
ListingUS NUVB
ISINUS67080N1019
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001811063
CIK0001811063
Employees307
AddressNuvation Bio, Inc. 1500 Broadway 10036, New York
Headline financial metrics
Revenue$114.9M
Operating income$-47.2M
Net income$-57.4M
Operating margin-41.0%
Net margin-50.0%
Return on equity-22.6%
Period2026
Loading chart…

Upcoming earnings

1 event
1:30 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.09
Est. revenue
34.8M

Earnings transcripts

3 recent

Documents

FormReporting forFiledFlags
2026-06-302026-08-06 6
—2026-03-31≈0
—2025-12-31≈0